First Time Loading...

Neurocrine Biosciences Inc
NASDAQ:NBIX

Watchlist Manager
Neurocrine Biosciences Inc Logo
Neurocrine Biosciences Inc
NASDAQ:NBIX
Watchlist
Price: 143.03 USD 3.99% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one NBIX stock under the Base Case scenario is 122.4 USD. Compared to the current market price of 143.03 USD, Neurocrine Biosciences Inc is Overvalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NBIX Relative Value
Base Case
122.4 USD
Overvaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.5
P/S
P/S
Price to Sales
7.5
vs History
60
vs Industry
56
Median 3Y
7.3
Median 5Y
8.6
Industry
8.1
Forward
6.2
More Details
56.5
P/E
P/E
Price to Earnings
56.5
vs History
58
vs Industry
3
Median 3Y
60.2
Median 5Y
63.2
Industry
26.2
Forward
28.3
More Details
36.2
P/OCF
P/OCF
Price to OCF
36.2
vs History
49
vs Industry
5
Median 3Y
34.1
Median 5Y
36.5
Industry
22.6
More Details
39.4
P/FCFE
P/FCFE
Price to FCFE
39.4
vs History
52
vs Industry
4
Median 3Y
38.9
Median 5Y
40.9
Industry
21.3
More Details
6.3
P/B
P/B
Price to Book Value
6.3
vs History
65
vs Industry
14
Median 3Y
6.3
Median 5Y
7.2
Industry
2.5
More Details
6.5
EV/S
EV/S
Enterprise Value to Sales
6.5
vs History
69
vs Industry
50
Median 3Y
6.8
Median 5Y
8
Industry
7.3
Forward
5.4
More Details
6.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.7
vs History
69
vs Industry
51
Median 3Y
6.9
Median 5Y
8.1
Industry
9.1
More Details
29.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
29.6
vs History
68
vs Industry
4
Median 3Y
33.3
Median 5Y
35.4
Industry
4.4
Forward
18.2
More Details
31.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
31.2
vs History
68
vs Industry
4
Median 3Y
35
Median 5Y
37.1
Industry
4.3
Forward
20.5
More Details
31.6
EV/OCF
EV/OCF
Enterprise Value to OCF
31.6
vs History
55
vs Industry
5
Median 3Y
31.1
Median 5Y
33.2
Industry
5.4
More Details
34
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
34
vs History
55
vs Industry
5
Median 3Y
33.3
Median 5Y
35.8
Industry
3.2
More Details
11
EV/IC
EV/IC
Enterprise Value to IC
11
vs History
38
vs Industry
22
Median 3Y
8.8
Median 5Y
10.5
Industry
5
More Details

Multiples Across Competitors

NBIX Competitors Multiples
Neurocrine Biosciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Neurocrine Biosciences Inc
NASDAQ:NBIX
14.1B USD 7.5 56.5 29.6 31.2
US
Abbvie Inc
NYSE:ABBV
285.6B USD 5.3 59.3 12.9 19.6
US
Amgen Inc
NASDAQ:AMGN
148.5B USD 5.3 22.1 16.4 24.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.6B USD 10.5 28.6 22.9 24
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
98.8B USD 7.5 25 16.6 18.2
AU
CSL Ltd
ASX:CSL
133B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
81.6B USD 3 168.6 6.8 8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
42.6B USD 6.2 -9 -9.5 -8.2
US
Biogen Inc
NASDAQ:BIIB
31.5B USD 3.3 27 13.8 17.3
KR
Celltrion Inc
KRX:068270
39.3T KRW 18.1 73.4 44.9 61.8

See Also

Summary
NBIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
NBIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NBIX stock valuation using valuation multiples.
Wall Street Estimates
NBIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NBIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.